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ABSTRACT 
JARED C BLACKER: Medication Use and Recovery in Orthognathic Surgery Patients 
(Under the direction of Ceib Phillips) 
 
Recovery from orthognathic surgery usually involves returning to pre-surgical levels 
of activity and function.  In this study, orthognathic surgery patients were given a daily diary 
to keep for 90 days post-surgery.  The diary measured recovery in four domains: post-
surgery sequelae, discomfort/pain, oral function, and daily activities.  This study evaluated 
the effect of medication use in patients on their reported recovery measures.  Multifactorial 
analysis according to age (< 18y, >18y), gender, type of surgery (maxilla, mandible, two-jaw 
surgery), and opioid analgesic use (< 7 days, >7 days) was performed.  Opioid use was 
significant as an interaction with age in some measures of the post-surgery sequelae 
domain.  Age had a significant main effect in daily activities, and significant interaction with 
type of surgery in oral function, post-surgery sequelae and pain/discomfort.   Older patients 
were more disparate in recovery according to type of surgery, while younger patients 
recovered more similarly given any type of surgery. 
 iv 
 
 
 
 
 
ACKNOWLEDGEMENTS 
 
In the completion of this thesis, the author wishes to thank those who have helped 
along the way:  Dr. Ceib Phillips for her mentorship and guidance; Dr. Sylvia Frazier-Bowers 
and Dr. George Blakey for their assistance as part of the thesis committee; Dr. Tim Wright, 
Dr. Greg Essick for their additional help; Mike Young for lab help, Atousa Safavi and Katy 
Strauss for patient recruitment and data management; Debbie Price for her statistical 
consulting. 
Additionally, Dr. William Proffit for providing many growth opportunities; Kyle and 
Deborah Blacker for being encouraging parents; Shane Blacker for an introduction to 
dentistry and orthodontics; and finally Adrienne Hardy Blacker for her love and constant 
support.   
 
 v 
 
 
 
 
 
TABLE OF CONTENTS 
 
LIST OF TABLES........................................................................................................... vi 
LIST OF FIGURES.........................................................................................................vii 
 
Chapter 
I. INTRODUCTION......................................................................................1 
II. REVIEW OF LITERATURE......................................................................3 
A. Use of Diaries.....................................................................................3 
B. Use of Medication Post-surgery..........................................................8 
III. METHODS.............................................................................................12 
A. Patients ............................................................................................12 
B. Instrument ........................................................................................12 
C. Analysis............................................................................................13 
IV. RESULTS ..............................................................................................14 
V. DISCUSSION.........................................................................................16 
A. Analysis............................................................................................16 
B. Data .................................................................................................16 
C. Definitions: Functional vs. Total Recovery ........................................19 
VI. CONCLUSIONS.....................................................................................21 
APPENDIX ........................................................................................................37 
REFERENCES ..................................................................................................38 
 
 vi 
LIST OF TABLES 
Table 
1. Cohort Descriptive Statistics ..................................................................................22 
2. Domain Measure Means and SEMs ......................................................................23 
3. Multifactorial Analysis of Oral Function, Daily Activities, and Discomfort................24 
4. Multifactorial Analysis of Acute and Longer Term Post Surgical Sequelae.............25 
5. Corrected Model Significance ................................................................................26 
 
 vii 
LIST OF FIGURES 
Figure 
1. Problem Days for Daily Activities According to Age ...............................................27 
2. Problem Days for Acute Sequelae According to Gender........................................28 
3. Problem Days for Longer Term Sequelae According to Type of surgery................29 
4. Interaction of Age and Type of Surgery on Oral Function.......................................30 
5. Interaction of Age and Type of Surgery on Longer Term Sequelae........................31 
6. Interaction of Age and Type of Surgery on Discomfort...........................................32 
7. Interaction of Age and Opioid Use on Longer Term Sequelae ...............................33 
8. Functional vs. Total Recovery in Oral Function by Opioid Use...............................34 
9. Functional vs. Total Recover in Daily Activities by Opioid Use...............................35 
10. Number of Medication Use Days by Opioid Use ....................................................36 
 1 
 
 
 
I. Introduction 
 Recovery from orthognathic surgery involves many components that will be faced by 
a surgery patient.  There are reasons it is important to describe the anticipated amount of 
time before recovery.  First, informed consent is based on communicating known information 
to the patient, so that patient may give consent to any recommended procedure.  Second, 
as far as we know recovery from surgery in some areas may take at least a week or more, 
and planning the convalescent period in terms of time off from work, needed care giving for 
the patient, and making time for follow-up visits are also concerns.  Any information we can 
gain from observing patients in the recovery period may be helpful in communicating 
realistic expectations to future orthognathic surgery patients.  Any factors that may alter or 
otherwise affect those observations may also be useful for patients to be aware of before 
surgery.   
 A structured diary is one way to record observations during the recovery period.  
While some studies have asked for observations that summarize a week or more of 
recovery,1, 2  a diary may be used for the time period immediately post-surgery.3  This 
method has been used previously in recovery from third molar surgery/extraction3 and more 
recently in an orthognathic surgery patient cohort.4, 5 After obtaining information in the form 
of structured diaries, it may be possible to assess factors that may elongate or shorten 
recovery times.   
 Prescribing medication for various reasons is common after orthognathic surgery.6  
Antibiotics, analgesics, anti-inflammation agents may be prescribed for patients.7-9  By 
evaluating the effects of taking medications for specific periods of time it may be possible to 
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understand better those recovery measures that either drive medication use, are affected by 
it, or are not influenced in either way.   
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II. Literature Review 
Introduction 
 
A post-surgical diary to record sequelae, complications, and recovery measures has 
been used to document patient reported outcomes.  Ultimately, the goal of keeping the diary 
is to capture data at fixed intervals (e.g. daily) that would otherwise be difficult to obtain.  In 
a situation like recovering from surgery, it proves difficult to have a subject respond to 
questions during post-surgical visits if the study protocol demands daily entries, yet the post-
surgical visits occur at weeks or months post surgery.   
 
Use of Diaries 
Many reports have been published regarding Health Related Quality of Life (HRQoL) 
relating to orthognathic surgery,1, 10-21 but the designs of those studies included gathering 
summarical post-surgery data (e.g. at 1 week, 4-6 weeks, etc.) which often coincides with 
the normal recall for the patients; i.e. the instruments used at these visits may ask for a 
summary of a time period that may be too long to demonstratively record changes in 
recovery measures that occur in hours or days.  For instance, the Oral Health Impact Profile 
(OHIP-14)2 asks patients to respond to questions as they recall events over the last 14 days, 
while the Post-Surgical Perceptions (PSP)1 asks for responses to summarize the previous 7 
days.  For those sequelae that may resolve sooner than a week, i.e. days or hours, other 
instruments and protocols are needed.   
 Structured diaries are one such method of recording information from  a shorter 
period of time, and have been used to capture information from patients following surgery.  
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Parsons, Cordes and Comer22 used data from patient journals to assess differences in 
patient recovery after using different surgical devices in tonsillectomy surgeries.  Their study 
included 134 surgery patients who were asked to complete the post-surgical diary for 10 
consecutive days.  The diary included a pain scale (Wong-Baker FACES pain rating scale23) 
and “questions about food intake, activity level, need for pain medication, and any 
complications experienced by the patient.”  
Tan et al24 also used diaries to assess pain and a few recovery measures after 
tonsillectomy procedures.  The 67 patients were asked to keep the diary for 21 days, during 
which the subject was asked to answer five questions: “1) visual analog score for pain of 0 
to 10, 0 being no pain and 10 being extreme pain; 2) number of tablets of analgesia taken 
for that day; 3) ability to take normal diet; 4) ability to return to normal activities; 5) 
experience of pain on swallowing.” 
Young and O’Connell25 used diaries to measure differences in recovery in patients 
who had laparascopic cholecystectomy in either a 23 hour or 8 hour facility.  28 patients 
were recruited and completed diaries for immediately post-surgical days.  The respondents 
reported scores on “tiredness, mobility, pain, eating and drinking, nausea and vomiting, 
elimination, wound management, discharge information and management of postoperative 
recovery.” 
Patient diaries are also used in many post-dental surgery recovery reports.  Froum et 
al26 used a diary card to have patients report on adverse events that occurred following the 
use of an Enamel Matrix Derivative (EMD) in the treatment of infrabony defects.  The study 
involved 376 patients form 11 university based postgraduate periodontal programs and 5 
private practices.  The diary in this study took the form of a card that the patient was 
instructed to complete as a summary for week 1 and week 2 post-surgery.  The card asked 
questions regarding “adverse events” and the data were recorded onto a case report form 
after being returned by the patient at follow-up appointments.   
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 Nusstein, Reader and Beck27 gave a diary to their 124 subjects to record “pain, 
percussion pain, swelling, and number and type of pain medication taken” after accessing, 
and drainage of, the pulp chamber in symptomatic necrotic teeth.  The diary keeping in this 
study occurred daily over a period of 6 days with the diaries being retuned at a follow-up 
visit.   
Nist, Reader and Beck28 also used a diary to assess the efficacy of apical 
trephination treatment on symptomatic necrotic teeth.  The 7-day, daily-diary also recorded 
“pain, percussion pain, swelling, and number and type of pain medication taken”.  Data were 
recorded on 50 adult patients, who were all instructed to complete the diary upon awakening 
on a given day.  The diary was returned at a return visit as well.   
 Kearns, McCartan and Lamey29 reported on the pain experience of 85 consecutive 
patients following biopsy of an oral mucosal lesion under local anesthesia.  The diary 
recorded three items: “the overall level of pain, the worst pain experienced and whether 
analgesics had been taken” over 7 post-operative days.  In this diary a Visual Analog Scale 
(VAS) was used for pain scores.   
 Heard et al30 also used a diary card to report on pain related sequela and wound 
healing in 32 patients who received EMD for the treatment of intrabony defects.  The diary 
card used in the study asked patients to give responses in the areas of “presence and 
severity of headaches, root hypersensitivity, tooth pain, swelling, and itching”.  The diaries 
were kept for 5 immediately post-surgery days.  Each question was in the form of Y/N with 
an accompanying question regarding the intensity of any “yes” answers (mild, moderate, or 
severe).  The data from the diaries were collected and compared at follow-up visits.   
 Houck et al31 used a 7 day diary to record “pain, percussion pain, swelling, and 
number and type of pain medication taken” in patients who underwent trephination treatment 
for symptomatic necrotic teeth.  Patients were instructed to complete the diary upon 
awakening and were asked to rate the different measures on a scale from 0 to 3, zero 
 6 
indicating no problem.  Diaries were collected at a follow up visit and verified for medication 
use.   
 Malstrom et al32, 33 twice used a diary to assess the efficacy of COX-2 inhibitors in the 
treatment of acute dental pain.  After the extraction of at least 2 third molars, patients were 
asked to observe and record “pain intensity, pain relief, and global evaluations throughout 
the 24-hour period after dosing”.  The diaries were used at the testing facility for the 8 hours 
following extraction, and then completed at 10, 12, and 24 hours post-surgery with the 
patients being reminded to complete the diary after receiving a phone call.     
 Pearlman et al34 used a patient diary to report on the efficacy of ibuprofen 
administration after periodontal surgery.  Patients were asked to record observations on 
“quantity and time of medication and regular assessment of pain experience utilizing a visual 
analogue scale”.  The 127 patients recorded scores in the diaries at either times when the 
patient was directed to take medication or at directed those same directed times (however, 
without also taking medication) and times when medication was deemed necessary by the 
patient.  The diary was kept until bedtime on the day of the surgery. 
In 1996, Cooper et al35 published a report to assess the efficacy of co-administration 
of misoprostol with NSAIDS which recorded pain levels for 6 hours post-surgery in a patient 
diary.  The publication reported on two studies including 70 patients in each study, differing 
in design by the type of NSAID used in combination with misoprostol.  The diaries were 
recorded in by the patient at 15, 30, 45 min and 1hour post-intervention/administration of 
medication and then every hour until 6 hours.   
In 1993 Cooper was again the lead author on a report that used a 12 hour diary to 
assess the efficacy of a time-release form of ibuprofen in the treatment of dental pain.36  120 
subjects were involved in the study and recorded in the diary to reports pain levels during 
post-intervention time periods of 1-4 hours,  5-8 hours and 9-12 hours or until rescue 
medication was need.  The diary was returned to the researchers at a follow-up visit.   
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 Marti et al37 used a self-report diary to assess the pain experience after minor dental 
surgery in patients who were taking either lysine clonixinate (NSAID) or paracetamol 
(acetaminophen).  These diaries were used for 48 hours following intervention or until pain 
resolution and directed the patient to report on pain levels using a VAS and other variables 
like “facial swelling and night pain”. 
 Tai and Baker38 had 52 patients complete a daily diary for one week post surgery for 
the removal of two lower third molars.  The diary was used to record "pain scores, 
consumption of paracetamol, dental bleeding, dysphagia and sleep disturbance” in patients 
who were administered either controlled release ketoprofen or diclofenac as an analgesic for 
pain control after removal of lower third molars. 
 Other studies have used diaries as an end to collect and report on the recovery of 
subjects, not just the means to compare different interventions.  Conrad et al39 and White et 
al3 used diaries to evaluate HRQol measures as patients recovered from third molar 
surgery.  Both studies utilized a 14 day diary keeping period to assess measures related to 
recovery.  The report from Conrad et al included diaries from 249 patients which evaluated 
patients along 4 main categories including pain, lifestyle, oral function and other symptoms.  
White et al used a similar diary to publish a follow-up report which involved 630 subjects.  
Foy et al40, Phillips et al41, and Stavropolous et al42 used White et al’s 14 day diaries to 
assess potential risk factors for prolonged recovery in patients who underwent third molar 
removal.   
 More recently, Phillips and Blakey5 used a modified version of the White et al3 14 day 
diary to assess recovery measures in orthognathic surgery patients.  One of the 
modifications made was to lengthen the time of diary completion by the patients from 14 to 
90 days.  87% of 170 enrollees completed the 90 day protocol, with younger patients being 
more likely to complete the entire 90 day diary.   
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 Phillips, Blakey, and Jaskolka4 reported the outcomes from the use of those 90 day 
diaries from the 170 patients including recovery times for the measures as asked in the 
diaries.  The authors assessed 4 recovery domains: post-surgery sequela, discomfort/pain, 
oral function, and daily activities.  All measures used a 5 point Likert-type scale, except for 
discomfort/pain which used a 7 point Likert-type scale.  With the type and amount of data 
recorded, those authors were able to report on median recovery times for the 
measurements listed in the diary.   
 
Use of Medication Post-Surgery  
 Prescribed medications for post-oral surgery sequelae can take the form of 
narcotics/opioids, non-steroidal anti-inflammatory drugs (NSAIDS), non-NSAID analgesics 
(acetaminophen), antibiotics, and others.6  Currently, the body of literature which 
recommends one type of medication use or another is replete with studies using a third 
molar extraction with or without impaction model,32-38, 43-56  or another type of dental surgery 
model, viz. periodontal surgery.57  For example, Tucker, Smith and Adams57 compared the 
effectiveness of using etodolac (NSAID) as opposed to a standard acetaminophen and 
hydrocodone (opioid) regimen in periodontal surgery population.  Chang et al47, 53, 58 
published results from several randomized clinical trials comparing the efficacy of rofecoxib 
(NSAID) in relieving surgical extraction of third molars to opioid and/or acetaminophen 
combinations.  Korn et al48 also published findings from a similar cohort in a randomized 
clinical trial, but in this report comparing rofecoxib to an oxycodone/acetaminophen 
combination.  While both studies found a greater analgesic effect in those patients in the 
NSAID group, rofecoxib was recalled by its manufacturer Merck in 2004.59 
There exist a few reports which have published post-surgical medication use in an 
orthognathic surgery patient population.  Antibiotics may be one class of medications 
prescribed to orthognathic surgery patients.  Chow et al7 and Zijderveld et al60 reported that 
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pre-operative intravenous administration of an antibiotic reduced the number of infections 
associated with orthognathic surgery.  Foy et al40 published similar findings in patients who 
had removal of third molars. 
Samman and Cheung61 reported on a prospective randomized clinical trial which 
involved 160 orthognathic patients being assigned to groups designated by increasing 
regimens of pre/post-surgical antibiotics.  While the overall infection rate was small for the 
cohort (16%), a significant difference was found between the group receiving the lowest 
amount of antibiotics (higher number of infections) and the group who received the greater 
dose of antibiotics.    
Steroids may be another class of drug prescribed for orthognathic surgery patients.  
Zuniga9 stated that steroid therapy may be useful in those patients who suffer inferior 
alveolar nerve damage during mandibular surgery, especially during bi-lateral sagittal split 
osteotomy (BSSO).   
Weber and Griffin62 reported on their randomized clinical trial involving 23 patients 
and the use of dexamethasone (a steroid).  Their findings included a reduced amount of 
edema experienced post-operatively.  The swelling was examined photographically, while c-
reactive protein, an indicator of inflammation was taken via blood sample and showed 
decreased amounts in those patients who received dexamethasone.   
Schaberg, Stuller and Edwards63 reported their finding and conclusion that 
methylprednisolone (a steroid) decreased the amount of swelling experienced by 
orthognathic surgery patients.  Their study included 39 patients who were assessed for 
edema post-surgically via computed tomography (CT) scans at 24 and 72 hours post-
operatively.   
Analgesics like NSAIDS, non-NSAIDS (e.g. acetaminophen) and opioids are often 
prescribed for orthognathic surgery patients.  Tuzuner et al64 report on their clincical trial 
where pre-operative use of tramadol (synthetic opioid) or diclofenac sodium (NSAID) were 
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evaluated for their effect on post-surgical consumption of intravenous opioids. Their study 
reported findings from a cohort of 36 patients who underwent both LeFort 1 maxillary 
advancement and BSSO as part of simultaneous bi-maxillary surgery.  While both tramadol 
and dicolfenac sodium gave more effective relief of pain than placebo, no difference 
emerged between the two medications.   
Nagatsuka, Ichinohe, and Kaneko65 also reported on the preemptive effects of a 
medley of medications on the post-surgery pain experiences of orthognathic surgery 
patients.  The medley of medications studied did not seem to cause the anticipated effect, 
as no differences were found between the experimental and control groups. 
Precious et al66 report from their study involving 75 subjects in 1997 where they 
compared post-operative pain management regiments of “patient-controlled intravenous (IV) 
opioid analgesic administration (PCA) with fixed schedule and dosage oral/rectal 
administration of naproxen, and opioid analgesics intramuscularly/orally as needed (IM/po 
prn) for postoperative analgesia over a period of 48 to 56 hours.”  Their findings included 
patients who were on the PCA and naproxen regiments reporting greater pain management 
compared to the codeine group, and that the codeine group experienced greater post-
surgical nausea. 
Evans, Levine and Bahn8 reported in 1976 about post-operative medication needs as 
observed in 45 recovering orthognathic surgery patients.  These authors remarked that a 
number of factors might contribute to severe pain during recovery, and therefore an opioid 
(i.e. more potent) drug may be needed.  In the cases reported, opioids, aspirin and 
acetaminophen were used to obtain adequate analgesia for post-surgery pain. 
Interestingly, Ichinohe and Kaneko67 reported that administering nitrous oxide during 
orthognathic surgery did not aggravate post-operative nausea and vomiting (PONV) in the 
28 female patients who participated in their study.  Silva, O’Ryan, and Poor68 who reported 
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that PONV is a common complaint among those who have undergone orthognathic surgery, 
and reported post-operative use of opioids as being a risk factor for PONV.   
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III. Methods 
Patients 
This study was approved by the Biomedical Institutional Review Board.  Subjects 
who were scheduled for an orthognathic surgical procedure after presenting with a 
dentofacial disharmony agreed to participate in a prospective clinical study.  Exclusion 
criteria included previous facial surgery; congenital anomaly or a history of acute facial trauma; 
medical condition associated with systemic neuropathy (e.g. diabetes, hypertension, kidney 
problems); pregnancy; or inability to follow written English instructions or unwilling to sign 
informed consent.  The project was described by a research associate after which HIPAA 
authorization and written consent/assent were obtained.  Demographic information including 
age, gender, and race was collected before surgery.  Surgery was performed by oral and 
maxillofacial surgery faculty and residents at UNC Hospitals.  All patients had orthodontic 
appliances in place at the time of surgery and rigid fixation to stabilize bony jaw segments. 
 
Instrument 
OSPostop, a patient-reported HRQoL structured diary,5 was used following 
orthognathic surgery.  Subjects were instructed to record perceived measures each post-
surgery day for 90 days.  The diary assessed four main areas: 1) post-surgery sequelae 
(feeling anxious, trapped, bleeding, bruising, nausea, food collection in the soft tissue 
incision, food collection around teeth, bad breath/bad taste, swelling); 2) discomfort/pain 
(worst, average, medication use); 3)oral function (opening, chewing, and biting foods); and 
4) daily activity (sleeping, routine, social and recreational activities). The discomfort/pain 
items were rated on Likert-like scales from No Discomfort (1) to Worst Imaginable (7).  All 
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other items were rated from No Trouble/Concern (1) to Lots of Trouble/Concern (5).    The 
subject was also requested to record whether medications had been taken for 
discomfort/pain and if so, what medications were taken (Appendix).  
 
Research associates met with the subjects at each clinical visit with the surgical 
attending.  Subjects were instructed to bring their diaries with them to follow-up visits 
occurring at one, four to six, and twelve weeks.  Research associates contacted subjects 
and requested the return, via postal service, of any diaries not collected because of a 
missed clinical visit or the subject neglecting to bring the diary with them to an appointment.   
A patient’s daily response to each of the items was dichotomized as no substantial 
interference or “little or no trouble/discomfort” as indicated by a 1 or 2 on the 5 point and 7 
point Likert-type scales and some substantial interference “some, quite a bit, or lots” as 
indicated by a response of 3 or higher on the 5-point and 7-point Likert-type scale for 
discomfort/pain.  Any day when a subject reported a 3 or higher was designated as a 
Problem Day (PD).  The number of PD for each measure within the four domains were then 
totaled and then compared using the factors of age, gender, type of surgery and opioid use.   
 
Analysis 
 Multifactorial ANOVA analysis was used to determine significant differences in the 
number of problem days and interactions between the factors within the diary measured 
domains.  All calculations were performed with SPSS 14.0 and the null rejection value was 
set at p < .05. 
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IV. Results 
 188 patients consented to participate in the study and completed at least the first 30 
days of the diary.  The patients who participated were primarily female (66.5%) and 
Caucasian (82.4%).  36.7% had a two jaw procedure, 37.8% had a maxillary procedure only 
and 25.5% had a mandibular only procedure (Table 1).  Participants ranged in age from 
13.9 years to 53.2 years (median = 18.5 years; IQR = 16.9-25.1 years).   
Subject factors included the number of days of opioid analgesic use (< 7 days and 
>7 days), gender, age (<18 y, >18y), and type of surgery (maxilla only, mandible only, and 
two jaw).  Multifactorial ANOVA was conducted to evaluate the effect of these factors on the 
number of problem days by domain that were reported in the diaries.  The domain of Post-
surgical sequelae were further segmented into acute (bruising, bleeding, nausea, feeling 
trapped, feeling anxious) and longer term (swelling, bad taste in the mouth, food collecting 
between teeth, and food collecting in incisions).  This was based on the mean number of 
problem days for the cohort as a whole (see Table 2).    
In the oral function domain none of the main effects were significant, however, the 
interaction between age and surgery was statistically significant (p=.047); in the corrected 
model all measures were significant: eating (p=.005), chewing (p=.041), and opening 
(p=.001).  In the daily activity domain only the main effect of age was significant (p=.012), 
however, there were no significant interactions between the factors; in the corrected model 
the measures of sleeping (p=.003) and social activities (p=.019) were significant.  For acute 
sequelae, the main effect of gender was significant (p=.003), yet there were again no 
significant interactions; however in the corrected model, bleeding was the one measure that 
was significantly different (p=.013).  For longer term sequelae, the main effect of type of 
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surgery was significant (p=.010), while the interactions between age and surgery (p=.015), 
and age and opioid use (p=.035) were also significant; in the corrected model swelling 
(p=.035), food collecting between or behind teeth (p<.001), and food collecting in soft tissue 
incisions (p=.008) were all significant.  Finally, for the discomfort domain no main effects 
were statistically significant, yet the interaction between age and surgery was again 
significant (p=.025); in the corrected model worst pain was significant (p=.037).  The factors’ 
main effects and two way interactions for oral function measures, daily activity measures, 
post-surgery sequelae, and discomfort are summarized in Tables 3 and 4.   Corrected model 
significance levels are shown in Table 5.   
 16 
 
 
 
V. Discussion 
Analysis 
The analysis of the data by PD allowed the study to overcome a definitional problem 
that would occur had we approached the data as a survival or “time to event” statistical 
model.  In other words, if the event of “resolution” is defined as the first pain free day, it 
becomes problematic to know how to treat a report of a painful day that occurs 3 days after 
the first pain free day.  By comparing total PD among the cohort, we are able to report the 
total number of PD a patient experiences at the cost of knowing how many of the PD occur 
consecutively; e.g. a patient may report 23 anxiety problem days, but the 23rd problematic 
day may have occurred at post-surgical day 29.  It seems reasonable to argue for reporting 
the data based on total PD, rather than a “time to resolution”, so that patients and their 
providers may be more aware of the total burden of the surgery, which may otherwise go 
undefined. 
 
Data 
 Age appeared to be the strongest determinant in our results, being significant as a 
main effect and as part of an interaction.  As a main effect, age was significant for the daily 
routine domain.  As a group, the younger patients appeared to have greater extremes in this 
domain, the younger patients report on average less trouble in sleeping PD than older 
patients, but more PD in the sports and hobbies measures (see Figure 1).  This could be a 
reflection of the schedules of young patients, many of whom may be engaged in more 
sports and activities on a daily basis than working or college age adults.  As for sleep 
disturbance, it appears that older patients report more PD than those younger patients.  
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Wang et al69 reported that patients who self-medicated after thoracotomy surgery 
experienced better pain control and less sleep disturbance than those who were given IM 
analgesics.  While the opioid use was not a significant main effect on this domain, in the 
corrected model, sleep was significantly different (p=.003), and those in the Op7+ group on 
average reported fewer sleep PD. 
Gender was significant as a main effect on the domain of acute post-surgical 
sequelae.  We see females reporting more PD in bruising, nausea, feeling anxious and 
feeling trapped than males, but males reporting more PD with bleeding (See Figure 2).  
While Silva et al68 reported females being more predisposed to nausea post orthognathic 
surgery, the only acute sequelae measure that was significant in our corrected model was 
bleeding (p=.013).   
Type of surgery was significant as a main effect for longer term post-surgical 
sequelae (See Figure 3).  Involvement of the mandible either alone or in two jaw surgery 
tended to result in more reported PD for a bad taste in the mouth, and food collecting in 
between teeth and soft tissue incisions.  Involvement of the maxilla, either alone or in two-
jaw surgery resulted in more swelling PD.  In our corrected model, swelling (p=.035), food 
collecting between teeth (p<.001), and food collecting in soft tissue incisions (p=.008) were 
all significant.   
 Age and surgery had significant interactions in three of the domains: oral function, 
longer term sequelae, and discomfort.  Younger patients seemed to be grouped closer 
together in PD among the oral function measures, i.e. the younger patients in all types of 
surgery had mean PD within 7 days of each other, which was not the case with older adults.  
The type of surgery had a greater impact on PD in older patients.  In older patients 
involvement of the mandible, either in mandible only or two jaw surgery, seemed to cause 
more PD (see Figure 4).  This may be an important factor in recommending one type of 
surgery or another to an older patient, especially in those surgery centers who tend to 
 18 
recommend more mandible only procedures than maxilla only procedures, as a matter of 
experience.  
 The interaction between age and surgery in longer term sequela also show a greater 
discrimination between surgery type in the older patient than the younger, especially in the 
measures of food collecting between teeth or in soft tissue incisions, and a bad taste 
occurring in the mouth.  Again, involvement of the mandible in older patients seems to 
influence greater PD reporting.   Swelling appears to bother younger patients more when 
there has been involvement of the maxilla, as opposed to two jaw surgery having generally 
more PD than either single jaw surgery in older patients (see Figure 5).  Kau, Cronin, and 
Richmond70 report that swelling is greater in two jaw surgery as measured by soft tissue 
laser scanning, which is suggested by the number of PD reported by the age groups, but the 
involvement of the maxilla in younger patients, being closer to two jaw surgery in terms of 
PD, is noteworthy.   
 Similar trends as those in longer term sequelae are seen in the discomfort measures, 
where involvement of the maxilla tends to cause more PD in average pain in the younger 
patients, but worst pain is similar across all three surgeries in the younger group.  Older 
patients report more PD in worst pain and average pain among those who have two jaw 
surgery, yet maxilla only surgery tends to be the lowest in PD in these measures (Figure 6).   
Age and opioid use had a significant interaction on longer term sequelae.  From this 
interaction we see that in every instance the older patients in the Op7 group reported 
greater PD than those in the Op7+ group.  As well, those in the Op7+ group were more 
closely similar in reported PD than those in the Op7 group across the age groups (see 
Figure 7).  This is an interesting finding, due to the fact that opioid analgesics are not 
generally used in the treatment of those long term sequelae, but what it may suggest is a 
tendency for those older Op7 subjects to go without analgesia for whatever the cause; this 
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could be a reflection of a watchful parent being able to administer analgesics to his or her 
child, or a self-responsible adult not wanting to spend money on prescription medication.    
 
Definitions: Functional vs. Total Recovery 
 The definition of a PD may also bear some consideration.  In this study we have 
defined a PD as when a patient reported a 3 or higher on the diary measures.  We may term 
this as a “functional recovery” because the subject may experience either no or a little 
problem with the particular measure, but it is assumed by our proposed definition of the PD 
that just a little problem should not interfere too greatly.  However, from a patient’s 
perspective, it may be worthwhile to know how long to expect until full recovery.   
 If we are to redefine a PD as a “total recovery”, i.e. anything other than a 1 on the 
Likert-type scales, our results do change, especially in regards to opioid use.  Particularly, 
when performing the same multifactorial analysis using a total recovery definition of a PD, 
then opioid use becomes significant as a main effect in both oral function (p=.018) and in 
daily activities (p<.001).  Figure 8 shows the comparison between the oral function 
measures when comparing the functional and total recovery models, while Figure 9 
demonstrates the differences between functional and total recovery for daily activities.   
Figure 10 demonstrates the mean medication use by the defined opioid use groups (Op7 
and Op7+).  This table summarizes the mean total number of days medication was used 
(NumMedDay), the mean total number of days opioids were used (NumOpDay) and the last 
day any type of medication was used (lastMedDay).  While NumMedDay and NumOpDay 
are not consecutive, lastMedDay represents the day at which medication was no longer 
needed as reported by the patient. 
The gap between functional and total recovery does not necessarily condemn 
functional recovery as useless.  For example, returning to Kau, Cronin and Richmond,70 
those authors reported that by 3 months, the mean resolution of swelling in each of their 
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patients was only 70%.   Even when comparing this to our total resolution data, the mean 
number of PD in swelling in our cohort was only 49 days, slightly more than half of the 90 
days in three months.  This reflects some sort of gap between a patient reporting a PD and 
some swelling being measured by a laser soft tissue scan.  Even though the PD are not 
consecutive, swelling tends decrease over time and should stay resolved, once resolved, 
barring infection or other complication.  Therefore, we may be able to plausibly suggest that 
a patient is able to cope with “a little problem,” i.e. functional recovery, rather than the 
defined functional recovery becoming an iatrogenically induced resolution. 
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VI. Conclusions 
 Age appeared to be the greatest determinant in the outcomes reported.  Age was 
found to be a significant main effect in the multifactorial ANOVA analysis, and was part of a 
several significant interactions.  Older patients may need more pain control in the form of 
opioid analgesics to be better prepared to cope with longer term sequelae; additionally, 
older patients who have two jaw surgery tend to experience more worst pain and average 
pain PD.  Older patients will typically experience more long term sequelae PD than younger 
patients, based on the type of surgery.  Younger patients seem to report a similar number of 
PD in oral function, whatever type of surgery may have occurred, but older maxilla only 
patients tend to fare better in oral function than when the mandible is involved.  Involvement 
of the mandible in older patients tends to increase the number of PD in a number of 
measures which should be considered when presenting treatment options.   
In addition, it may be recommended that because some patients may be using 
medication for total resolution purposes, and not just functional resolution, providers should 
be prepared to help patients make an appropriate transition from opioids to other 
analgesics.  Additionally, some patients may need stronger analgesics longer than others, 
therefore an awareness of patient problems in some of the diary measures may allow 
providers to feel more comfortable with prescribing additional opioid analgesics. 
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Table 1 
 
 
  N % 
Female 124 65.9 
Male 64 34.1 
Caucasian 155 82.4 
Other 33 17.6 
Maxilla only 71 37.8 
Mandible only 48 25.5 
Two Jaw 69 36.7 
 
Cohort Descriptive Statistics 
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Table 2 
 
 
DOMAINS DIARY MEASURES Mean SEM 
Eating 41.91 1.80 
Chewing 47.12 1.69 Oral Function 
Opening 39.16 1.83 
  
Sleeping 10.95 0.91 
Talking 18.04 1.00 
Daily Routine 18.32 1.15 
Social Activities 20.87 1.27 
Daily Activities 
Sports and Hobbies 32.59 1.63 
  
Bruising 5.01 0.46 
Bleeding 3.59 0.30 
Nausea 2.52 0.29 
Feeling Anxious 6.27 0.71 
Acute  
Post-surgery 
Sequelae 
Feeling Trapped 5.04 0.73 
  
Swelling 16.38 1.03 
Bad Taste in Mouth 11.85 0.96 
Food collecting between teeth 19.37 1.34 
Long Term 
Post-surgery 
Sequelae 
Food collecting in incisions 10.76 1.15 
  
Worst Pain 22.28 1.47 Discomfort 
Average Pain 13.71 1.06 
 
Domain Measure Means and Standard Error of the Mean (SEM) 
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Table 3 
 
 
 
 
 
 
Oral Function Daily Activities Discomfort 
Explanatory 
Variable Wilks' Lambda Sig.  
Wilks' 
Lambda Sig.  
Wilks' 
Lambda Sig.  
Gender .982 .373 .951 .128 .997 .788 
Age .977 .261 .918 .012 .992 .500 
Surgery .963 .379 .938 .361 .964 .175 
Opioid Use .957 .059 .941 .066 .967 .057 
Interaction             
Gender and 
Age .959 .065 .976 .540 .992 .486 
Gender and 
Surgery .947 .150 .919 .156 .978 .435 
Gender and 
Opioid Use .962 .081 .970 .403 .988 .355 
Age and 
Surgery .928 .047 .928 .231 .938 .025 
Age and 
Opioid Use .969 .150 .953 .142 .989 .374 
Surgery and 
Opioid Use .951 .195 .962 .759 .980 .477 
 
Multifactorial Analysis of Oral Function, Daily Activities, and Discomfort 
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Table 4 
 
 
 
 
 
 Acute Sequelae Longer Term Sequelae 
Explanatory 
Variable Wilks' Lambda Sig.  Wilks' Lambda Sig.  
Gender .902 .003 .951 .070 
Age .970 .392 .959 .131 
Surgery .908 .086 .889 .010 
Opioid Use .997 .994 .991 .832 
Interaction         
Gender and Age .982 .675 .991 .812 
Gender and 
Surgery .980 .970 .958 .503 
Gender and 
Opioid Use .965 .295 .974 .334 
Age and Surgery .944 .457 .895 .015 
Age and Opioid 
Use .969 .371 .941 .035 
Surgery and 
Opioid Use .948 .514 .927 .113 
 
Multifactorial Analysis of Acute and Longer Term Post Surgical Sequelae 
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Table 5 
 
DOMAINS DIARY MEASURES Corrected model Sig. 
Eating .005 
Chewing .041 Oral Function 
Opening .001 
  
Sleeping .003 
Talking .785 
Daily Routine .206 
Social Activities .019 
Daily 
Activities 
Sports and Hobbies .293 
  
Bruising .240 
Bleeding .013 
Nausea .615 
Feeling Anxious .721 
Acute     
Post-
surgery 
Sequelae 
Feeling Trapped .357 
  
Swelling .035 
Bad Taste in Mouth .210 
Food collecting between teeth <.001 
Long 
Term 
Post-
surgery 
Sequelae 
Food collecting in incisions .008 
  
Worst Pain .037 
Discomfort 
Average Pain .088 
 
Corrected Model Significance 
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Figure 1 
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Problem Days for Daily Activities According to Age 
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Problem Days for Acute Sequelae According to Gender 
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Problem Days for Longer Term Sequelae According to Type of Surgery 
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Interaction of Age and Type of Surgery on Oral Function 
Fig
u
re
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Interaction of Age and Type of Surgery on Longer Term Sequelae 
Fig
u
re
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Interaction of Age and Type of Surgery on Discomfort 
Fig
u
re
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Interaction of Age and Opioid Use on Longer Term Sequelae 
Fig
u
re
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Functional vs. Total Recovery in Oral Function by Opioid Use 
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Functional vs. Total Recovery in Daily Activities by Opioid Use 
Fig
u
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Functional  
 
Total 
 
Number of Medication Use Days by Opioid Use 
 
NumOpDay = number of days opioids were used 
NumMedDay = number of days any type of medication was used 
lastMedDay = last day any type of medication was used 
 
Figure 10 
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